Deppen spoke about biological, population and technology issues related to the discovery and implementation of biomarkers for early cancer detection.

The project will create the Urinary Stone Disease Hub, known as USDHub, with de-identified patient data from over 230,000 individuals with kidney stone disease across nine health systems in the U.S.

Developed in the wake of the COVID-19 pandemic, ReVAMPP will support a coordinating center and seven research centers, including VUMC, with a focus on nine virus groups that pose the greatest risk to human health.

The awards honor staff members who provide exemplary support at all levels across the research enterprise. Their contributions to research are unmatched and invaluable to the science conducted at Vanderbilt.

Researchers must continually chase funding for their work. Kelly Dooley's prestigious award from the NIH is intended to help provide respite from that chase.

VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.

Early detection opens the door to intervention via noninvasive neuromodulation for those with treatment-resistant symptoms of psychotic disorders like schizophrenia.